MB

Martin Bolli

IP Idorsia Pharmaceuticals: 14 patents #2 of 104Top 2%
📍 Allschwil, CH: #1 of 309 inventorsTop 1%
Overall (All Time): #34,408 of 4,157,543Top 1%
64
Patents All Time

Issued Patents All Time

Showing 1–25 of 64 patents

Patent #TitleCo-InventorsDate
12410208 (2-acetamidyl)thio-beta-D-galactopyranoside derivatives Daniel Bur, John Gatfield, Corinna Grisostomi, Lubos Remen, Cornelia Zumbrunn 2025-09-09
12404295 (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives Daniel Bur, John Gatfield, Corinna Grisostomi, Lubos Remen, Cornelia Zumbrunn 2025-09-02
12344597 Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis Christine Brotschi, Cyrille Lescop, Jodi T. Williams 2025-07-01
12319672 Alpha-D-galactopyranoside derivatives John Gatfield, Corinna Grisostomi, Lubos Remen, Christoph SAGER, Cornelia Zumbrunn 2025-06-03
12312362 Spiro derivatives of Alpha-D-galactopyranosides John Gatfield, Corinna Grisostomi, Lubos Remen, Christoph SAGER, Cornelia Zumbrunn 2025-05-27
12304902 Hydroxyheterocycloalkane-carbamoyl derivatives John Gatfield, Corinna Grisostomi, Lubos Remen, Christoph SAGER, Cornelia Zumbrunn 2025-05-20
12297189 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Markus Von Raumer 2025-05-13
12291520 Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives John Gatfield, Corinna Grisostomi, Lubos Remen, Christoph SAGER, Cornelia Zumbrunn 2025-05-06
12291519 2-hydroxycycloalkane-1-carbamoyl John Gatfield, Corinna Grisostomi, Lubos Remen, Christoph SAGER, Cornelia Zumbrunn 2025-05-06
12144811 Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for the treatment of endothelin related diseases Marc Bellet, Marc Iglarz 2024-11-19
11787782 Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Marc Bellet, Martine Clozel, Marc Iglarz 2023-10-17
11680058 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Markus Von Raumer 2023-06-20
11174247 Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Marc Bellet, Martine Clozel, Marc Iglarz 2021-11-16
11136317 NADPH oxidase 4 inhibitors Hamed Aissaoui, Christoph Boss, Sylvia Richard-Bildstein, Patrick Sieber 2021-10-05
10919881 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Philipp KOHLER, Ivan SCHINDELHOLZ, Markus Von Raumer 2021-02-16
10584118 NADPH oxidase 4 inhibitors Hamed Aissaoui, Christoph Boss, Sylvia Richard-Bildstein, Patrick Sieber 2020-03-10
9617250 Pyridin-4-yl derivatives Cyrille Lescop, Oliver Nayler, Beat Steiner 2017-04-11
9493446 Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives Christoph Boss, Christine Brotschi, Markus Gude, Bibia Heidmann, Thierry Sifferlen +1 more 2016-11-15
9403813 Azetidine amide derivatives as orexin receptor antagonists Christoph Boss, Christine Brotschi, Bibia Heidmann, Thierry Sifferlen, Jodi T. Williams 2016-08-02
9303023 Pyrazole and imidazole derivatives useful as orexin antagonists Christoph Boss, Christine Brotschi, Markus Gude, Bibia Heidmann, Thierry Sifferlen +1 more 2016-04-05
9150566 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists Christoph Boss, Christine Brotschi, Bibia Heidmann, Thierry Sifferlen, Jodi T. Williams 2015-10-06
9133179 2-methoxy-pyridin-4-yl-derivatives Cyrille Lescop, Boris Mathys, Keith Morrison, Claus Mueller, Oliver Nayler +1 more 2015-09-15
8912340 Process for the preparation of 2-imino-thiazolidin-4-one derivatives Stefan Abele, Gunther Schmidt 2014-12-16
RE45174 Thiazolidin-4-one derivatives Christoph Binkert, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler 2014-09-30
8697732 Pyridine derivatives David Lehmann, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner +1 more 2014-04-15